SAN DIEGO - TelAve -- OncosAI.com, a free cancer information platform run by The J.T. Gram Foundation, has served 87,000 users in 85 countries and answered more than 1.9 million interactions since launching in January 2026. The platform works in 36 languages and has grown entirely through word of mouth, with no paid marketing.

After a cancer diagnosis, most patients search online first. What they find is a mix of trusted institutions, unproven cures and outright scams, often with no clear way to tell them apart. For patients who do not read English, trustworthy options are even harder to find.

"When someone hears 'you have cancer,' the first thing they do is search online, and too often they find misinformation," said John T. Gram, founder and president of The J.T. Gram Foundation. "We built OncosAI so every patient, in any language, can get answers they can trust, for free."

More on TelAve News

• RAS AP Consulting Issues National Compliance Alert and Launches Q4 2026 AP Readiness Program Ahead of IRS FIRE → IRIS Cutover
• Claude Zdanow named Managing Director in Miami, Florida
• Pregis Launches Sharp InfinX: On-Demand Rightsized Mailing System Delivering a Precision-Sized Mailer for Every Order
• netElastic Announces vBNG And CGNAT 2.0 General Availability
• Evergreen Surety Launches Telecommunications Surety Bonds Page as Broadband and 5G Buildout Expands Obligee Requirements

OncosAI answers questions in plain language, 24 hours a day, at no cost. It draws only on verified medical sources, such as the National Cancer Institute and ClinicalTrials.gov, and cannot pull from the open internet, so it does not repeat the misinformation patients encounter elsewhere. Every answer includes citations, allowing patients and caregivers to check the evidence themselves. The platform stores no patient data and will never sell or monetize it. Ninety percent of users report being satisfied with the service.

Language access is central to the platform's reach. By working in 36 languages, OncosAI gives immigrant families and patients around the world reliable answers in their own language during one of the most difficult moments of their lives.

The foundation plans to add more languages, clinical trial search and partnerships with cancer centers and patient-support organizations, expanding as funding allows.

More on TelAve News

• Postmortem Pathology Highlights Private Autopsy Options for Las Vegas Families During Summer Months
• Postmortem Pathology Offers Sacramento Families Independent Answers on a Short Timeline
• NEW Three Fully Furnished Single-Family Model Homes at Heritage at South Brunswick
• After 35 Years, Christian Radio Host Marina Maria Publishes the Novel She Never Forgot
• Freight Broker 911 CEO and President Milton Collier Is Rebuilding the Path Into Freight Brokerage

Gram founded The J.T. Gram Foundation in 2025 after 32 years in the biopharmaceutical industry, bringing that experience to a problem patients face from the first moments after diagnosis.

Connect is sharing this announcement as part of its ongoing work to amplify the founders, organizations and innovations advancing the region's innovation economy.

About The J.T. Gram Foundation
The J.T. Gram Foundation is a San Diego County 501(c)(3) (EIN 41-3124270) founded by John T. Gram, a 32-year biopharmaceutical industry veteran. Its mission is to ensure every cancer patient has free access to trustworthy medical information, regardless of language, location or income.

Learn more about The J.T. Gram Foundation at https://jtgram.com.